Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Tilray Launching New Medical Marijuana Brand


Tilray (NASDAQ: TLRY) is expanding its medical marijuana suite of products. The Canadian marijuana company announced Tuesday that it has rolled out a new line of medical goods in that country called Symbios. This covers a variety of formats, including flower, pre-rolled cigarettes, and oils.

The company, which was enlarged by an effective takeover by peer Canadian pot company Aphria that closed last month, is also launching a new line of high-potency medical topical products under the Aphria brand. These are intended for the treatment of inflammatory joint disease.

Users can opt for a formulation that consists of 750 milligrams of cannabidiol (CBD), or a mix of 375 milligrams each of CBD and tetrahydrocannabinol (THC).

Continue reading


Source Fool.com

Like: 0
Share

Comments